260 related articles for article (PubMed ID: 24710520)
1. Dysregulated gene expression in the primary osteoblasts and osteocytes isolated from hypophosphatemic Hyp mice.
Miyagawa K; Yamazaki M; Kawai M; Nishino J; Koshimizu T; Ohata Y; Tachikawa K; Mikuni-Takagaki Y; Kogo M; Ozono K; Michigami T
PLoS One; 2014; 9(4):e93840. PubMed ID: 24710520
[TBL] [Abstract][Full Text] [Related]
2. Bone proteins PHEX and DMP1 regulate fibroblastic growth factor Fgf23 expression in osteocytes through a common pathway involving FGF receptor (FGFR) signaling.
Martin A; Liu S; David V; Li H; Karydis A; Feng JQ; Quarles LD
FASEB J; 2011 Aug; 25(8):2551-62. PubMed ID: 21507898
[TBL] [Abstract][Full Text] [Related]
3. Excessive Osteocytic Fgf23 Secretion Contributes to Pyrophosphate Accumulation and Mineralization Defect in Hyp Mice.
Murali SK; Andrukhova O; Clinkenbeard EL; White KE; Erben RG
PLoS Biol; 2016 Apr; 14(4):e1002427. PubMed ID: 27035636
[TBL] [Abstract][Full Text] [Related]
4. Osteocyte-specific deletion of Fgfr1 suppresses FGF23.
Xiao Z; Huang J; Cao L; Liang Y; Han X; Quarles LD
PLoS One; 2014; 9(8):e104154. PubMed ID: 25089825
[TBL] [Abstract][Full Text] [Related]
5. Distinct roles for intrinsic osteocyte abnormalities and systemic factors in regulation of FGF23 and bone mineralization in Hyp mice.
Liu S; Tang W; Zhou J; Vierthaler L; Quarles LD
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1636-44. PubMed ID: 17848631
[TBL] [Abstract][Full Text] [Related]
6. Conditional Deletion of Murine Fgf23: Interruption of the Normal Skeletal Responses to Phosphate Challenge and Rescue of Genetic Hypophosphatemia.
Clinkenbeard EL; Cass TA; Ni P; Hum JM; Bellido T; Allen MR; White KE
J Bone Miner Res; 2016 Jun; 31(6):1247-57. PubMed ID: 26792657
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic role of Fgf23 in Hyp mice.
Liu S; Zhou J; Tang W; Jiang X; Rowe DW; Quarles LD
Am J Physiol Endocrinol Metab; 2006 Jul; 291(1):E38-49. PubMed ID: 16449303
[TBL] [Abstract][Full Text] [Related]
8. Osteocytes and the pathogenesis of hypophosphatemic rickets.
Yamazaki M; Michigami T
Front Endocrinol (Lausanne); 2022; 13():1005189. PubMed ID: 36246908
[TBL] [Abstract][Full Text] [Related]
9. Aberrant Phex function in osteoblasts and osteocytes alone underlies murine X-linked hypophosphatemia.
Yuan B; Takaiwa M; Clemens TL; Feng JQ; Kumar R; Rowe PS; Xie Y; Drezner MK
J Clin Invest; 2008 Feb; 118(2):722-34. PubMed ID: 18172553
[TBL] [Abstract][Full Text] [Related]
10. Regulation of bone-renal mineral and energy metabolism: the PHEX, FGF23, DMP1, MEPE ASARM pathway.
Rowe PS
Crit Rev Eukaryot Gene Expr; 2012; 22(1):61-86. PubMed ID: 22339660
[TBL] [Abstract][Full Text] [Related]
11. Novel regulators of Fgf23 expression and mineralization in Hyp bone.
Liu S; Tang W; Fang J; Ren J; Li H; Xiao Z; Quarles LD
Mol Endocrinol; 2009 Sep; 23(9):1505-18. PubMed ID: 19556340
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the DMP1 C-terminal fragment stimulates FGF23 and exacerbates the hypophosphatemic rickets phenotype in Hyp mice.
Martin A; David V; Li H; Dai B; Feng JQ; Quarles LD
Mol Endocrinol; 2012 Nov; 26(11):1883-95. PubMed ID: 22930691
[TBL] [Abstract][Full Text] [Related]
13. [Osteocyte and DMP1].
Toyosawa S; Oya K; Sato S; Ishida K
Clin Calcium; 2012 May; 22(5):713-20. PubMed ID: 22549196
[TBL] [Abstract][Full Text] [Related]
14. Extracellular Phosphate Induces the Expression of Dentin Matrix Protein 1 Through the FGF Receptor in Osteoblasts.
Nishino J; Yamazaki M; Kawai M; Tachikawa K; Yamamoto K; Miyagawa K; Kogo M; Ozono K; Michigami T
J Cell Biochem; 2017 May; 118(5):1151-1163. PubMed ID: 27639037
[TBL] [Abstract][Full Text] [Related]
15. PHEX mimetic (SPR4-peptide) corrects and improves HYP and wild type mice energy-metabolism.
Zelenchuk LV; Hedge AM; Rowe PS
PLoS One; 2014; 9(5):e97326. PubMed ID: 24839967
[TBL] [Abstract][Full Text] [Related]
16. Osteomalacia in hyp mice is associated with abnormal phex expression and with altered bone matrix protein expression and deposition.
Miao D; Bai X; Panda D; McKee M; Karaplis A; Goltzman D
Endocrinology; 2001 Feb; 142(2):926-39. PubMed ID: 11159866
[TBL] [Abstract][Full Text] [Related]
17. Hexa-D-arginine treatment increases 7B2•PC2 activity in hyp-mouse osteoblasts and rescues the HYP phenotype.
Yuan B; Feng JQ; Bowman S; Liu Y; Blank RD; Lindberg I; Drezner MK
J Bone Miner Res; 2013 Jan; 28(1):56-72. PubMed ID: 22886699
[TBL] [Abstract][Full Text] [Related]
18. Complex intrinsic abnormalities in osteoblast lineage cells of X-linked hypophosphatemia: Analysis of human iPS cell models generated by CRISPR/Cas9-mediated gene ablation.
Nakanishi T; Yamazaki M; Tachikawa K; Ueta A; Kawai M; Ozono K; Michigami T
Bone; 2024 Apr; 181():117044. PubMed ID: 38331306
[TBL] [Abstract][Full Text] [Related]
19. Growth-related skeletal changes and alterations in phosphate metabolism.
Michigami T; Tachikawa K; Yamazaki M; Nakanishi T; Kawai M; Ozono K
Bone; 2022 Aug; 161():116430. PubMed ID: 35577326
[TBL] [Abstract][Full Text] [Related]
20. Osteocytes but not osteoblasts directly build mineralized bone structures.
Wang K; Ren Y; Lin S; Jing Y; Ma C; Wang J; Yuan XB; Han X; Zhao H; Wang Z; Zheng M; Xiao Y; Chen L; Olsen BR; Feng JQ
Int J Biol Sci; 2021; 17(10):2430-2448. PubMed ID: 34326685
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
